Turin, Italy

Paola Cappello

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Torino, IT (2011)
  • Turin, IT (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paola Cappello: Innovator in Cancer Diagnosis and Treatment

Introduction

Paola Cappello is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of pancreatic adenocarcinoma. With a total of 2 patents, her work has the potential to impact the lives of many patients.

Latest Patents

Cappello's latest patents include an isolated monophosphorylated peptide derived from human alpha-enolase, which is useful for the diagnosis and treatment of pancreatic adenocarcinoma. This invention provides a peptide of 12-20 amino acids in length, featuring a phosphorylated serine residue at position 8. Additionally, she has developed antibodies that specifically bind to this peptide and isoform, which may be utilized in the diagnosis and treatment of pancreatic adenocarcinoma. Another significant patent involves novel human protein antigens and related antibodies that are specifically expressed in association with pancreatic ductal adenocarcinoma. These proteins and antibodies can be instrumental in diagnosing and treating PDA and other cancers with similar molecular features.

Career Highlights

Throughout her career, Paola Cappello has worked with notable companies such as Ribovax Biotechnologies and Bioline Diagnostici. Her innovative research has positioned her as a key figure in the biotechnology sector, focusing on cancer diagnostics.

Collaborations

Cappello has collaborated with esteemed colleagues, including Francesco Novelli and Barbara Tomaino. These partnerships have further enhanced her research and contributions to the field.

Conclusion

Paola Cappello's work in cancer research, particularly her patents related to pancreatic adenocarcinoma, showcases her dedication to improving diagnostic and treatment methods. Her contributions are vital in the ongoing fight against cancer, and her innovations hold promise for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…